by MH Team | Nov 10, 2024 | White Blood Cells
Key Takeaways What is CAR T-cell therapy? ▾ CAR T-cell treatment is a type of immunotherapy that uses a patient’s own T-cells to fight cancer. T-cells are genetically engineered to express a chimeric antigen receptor (CAR) that recognizes and targets...
by MH Team | Nov 3, 2024 | Red Blood Cells
Key Takeaways Fanconi Anemia (FA) is a rare, inherited genetic disorder that primarily affects the bone marrow and increases the risk of cancer. Key Symptoms ▾ Bone Marrow Failure: Leading to anemia, thrombocytopenia, and neutropenia. Congenital Abnormalities:...
by MH Team | Oct 29, 2024 | Platelet Disorders
Key Takeaways Hereditary Hemorrhagic Telangiectasia (HHT) is a rare genetic disorder that causes abnormal blood vessels to form throughout the body. Key characteristics of HHT include: Telangiectases: Tiny, dilated blood vessels on the skin and mucous membranes....
by MH Team | Oct 25, 2024 | Red Blood Cells
Key Takeaways Neonatal jaundice (high bilirubin levels in newborns) is a common condition in newborns characterized by the yellowing of the skin and eyes due to an elevated level of bilirubin in the blood. It is typically caused by the baby’s immature liver or...
by MH Team | Oct 14, 2024 | Red Blood Cells
Key Takeaways Jaundice is a condition characterized by a yellowish discoloration of the skin, eyes, and mucous membranes. It occurs when there is an excessive buildup of bilirubin (hyperbilirubinemia), a yellow pigment produced by the breakdown of red blood cells, in...
Recent Comments